診断における人工知能の世界市場2020-2026:診断種類別(放射線、腫瘍学、神経学、心臓病学、胸部・肺、病理学、その他)、コンポーネント別、地域別

◆英語タイトル:Global Artificial Intelligence in Diagnostics Market By Diagnosis Type (Radiology, Oncology, Neurology, Cardiology, Chest & Lungs, Pathology and Other Diagnosis Types), By Component (Services, Software and Hardware), By Region, Industry Analysis and Forecast, 2020 - 2026
◆商品コード:KBV20OCT109
◆発行会社(リサーチ会社):KBV Research
◆発行日:2020年7月31日
◆ページ数:130
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ、カナダ、メキシコ、ロシア、ドイツ、イギリス、フランス、スペイン、イタリア、中国、日本、インド、韓国、シンガポール、マレーシア、ブラジル、アルゼンチン、アラブ首長国連邦、サウジアラビア、南アフリカ、ナイジェリア
◆販売価格オプション(消費税別)
Single User(1名様利用)USD3,600 ⇒換算¥388,800見積依頼/購入/質問フォーム
Global License(法人利用)USD6,048 ⇒換算¥653,184見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はKBV Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
KBV Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本市場調査レポートでは、診断における人工知能の世界市場について、市場範囲・調査手法、市場概要、競争分析、診断種類別(放射線、腫瘍学、神経学、心臓病学、胸部・肺、病理学、その他)分析、コンポーネント別分析、地域別分析、企業概要などを総合的、多面的に調査・分析しました。
・市場範囲・調査手法
・市場概要
・競争分析
・診断における人工知能の世界市場規模:診断種類別(放射線、腫瘍学、神経学、心臓病学、胸部・肺、病理学、その他)
・診断における人工知能の世界市場規模:コンポーネント別
・診断における人工知能の世界市場規模:地域別
・企業概要
【レポートの概要】

The Global Artificial Intelligence in Diagnostics Market size is expected to reach $1.3 billion by 2026, rising at a market growth of 27.4% CAGR during the forecast period. Artificial intelligence in healthcare is one of the most important scientific advancements in medicine so far. The participation of several start-ups in the development of AI-driven imaging and diagnostic solutions is a key factor contributing to the growth of the sector.

Artificial intelligence applications vary from image acquisition, processing to aided reporting, follow-up, data storage, data mining, etc. The report provides a balance between threats to AI and opportunities for radiologists in the modern medical world. The use of machine learning combines computational models and algorithms that replicate the brain’s biological neural network architecture, i.e., artificial neural networks (ANNs). Output wise Deep learning has a higher rate of success relative to conventional machine learning.

The growing amount of data to be processed can affect how radiologists view images, i.e. from inference to identification and explanation. If too many images are processed by radiologists in a day, the odds of error rise, while at the same time the radiologist is reduced to being a pure “image analyst.” The clinical interpretation of the findings shall be left to other physicians or specialists. In other words, if radiologists do not have time for professional judgment or circumstances such as Indian or Eastern Europe or the African market where there is a lack of radiologists, the final evaluation of radiological tests will be left to non-experts in medical imaging.

Based on Diagnosis Type, the market is segmented into Radiology, Oncology, Neurology, Cardiology, Chest & Lungs, Pathology and Other Diagnosis Types. Based on Component, the market is segmented into Services, Software and Hardware. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Siemens AG (Siemens Healthineers), Aidoc Medical Ltd., AliveCor, Inc., Imagen Technologies, Inc., VUNO, Inc., IDx Technologies, Inc., NovaSignal Corporation, Riverain Technologies, LLC, and Zebra Medical Vision Ltd.

Strategies deployed in Artificial Intelligence in Diagnostics Market
Partnerships, Collaborations, and Agreements:

Jun-2020: GE Healthcare announced collaboration with Lunit, a South Korean startup. Together with Lunit, GE launched an artificial intelligence-powered chest X-ray analysis suite. The suite has been designed to spot and highlight eight common conditions, using algorithms built by Lunit.
Jun-2020: Siemens signed an agreement with Geisinger, a healthcare provider. The agreement was focused on accessing diagnostic imaging equipment and artificial intelligence applications. The partnership would advance and support elements of its strategic priorities related to continually improving care for their patients, communities and the region.
May-2020: Aidoc collaborated with Telemedicine Clinic (TMC), the teleradiology unit of leading European diagnostics group Unilabs. Following the collaboration, Telemedicine Clinic rolled out Aidoc’s radiology AI solution across its network, ensuring the highest quality of diagnosis for TMC patients around the world.
Apr-2020: AliveCor came into partnership with Medable, Inc., the leading global platform for decentralized clinical trials. The partnership was focused on dramatically scaling remote clinical trials by enabling in-home ECGs with AliveCor’s KardiaMobile6L, the six-lead personal ECG.
Feb-2020: Aidoc teamed up with LucidHealth, a physician-owned and led radiology company. Under this collaboration, the latter company was aimed to use an AI-powered diagnostic aid from the former company to help prioritize and expedite treatment to patients with critical, life-threatening conditions.
Dec-2019: Zebra Medical Vision announced its collaboration with Johnson & Johnson’s DePuy Synthes. The collaboration was focused on jointly bringing Cloud-based AI solutions to the orthopedic and bone health industry. Under the partnership, Zebra Medical Vision’s machine learning algorithms are being used to create three-dimensional models of patients from X-ray images.
Nov-2019: Zebra Medical Vision teamed up with Nuance following which its AI1 “all-in-one” bundle of artificial intelligence (AI) products would available on the Nuance AI Marketplace. Nuance offers the first and largest portal with one-stop access to a wide range of AI diagnostic models. The Nuance AI Marketplace functions like an app store that is dedicated to radiology. I
Apr-2019: GE Healthcare collaborated with ACR AI-LAB following which GE’s Edison has been integrated with ACR AI-LAB. The Edison platform helps in accelerating the development and adoption of Artificial Intelligence (AI) technology and empowers providers to deliver faster, more precise care. By integrating with ACR AI-LAB, it extended these services and enabled ACR members and other radiology professionals to more easily develop and seamlessly deploy their algorithms across hospitals and research centers nationally.
Apr-2019: Siemens Healthineers teamed up with Intel, the semiconductor manufacturing firm. The collaboration was aimed on break-through artificial intelligence (AI)-based cardiac MRI segmentation and analysis model that has the potential to provide real-time cardiovascular disease diagnosis.
Jan-2019: GE Healthcare partnered with Intel, a Semiconductor manufacturing firm. The partnership was aimed to deploy deep learning AI to reduce the time between medical imaging, diagnoses, and beginning treatment. Together, the companies have been providing physicians with automated diagnostic alerts for some circumstances within seconds of medical imaging being completed. It encompassed the Intel Distribution of OpenVINO toolkits, working on Intel processor-based X-ray systems to assist prioritize and streamline patient care.
Oct-2018: IDx came into an agreement with Topcon, a manufacturer of optical equipment for ophthalmology and surveying. The agreement was aimed to sell its artificial intelligence-based diagnostic system with the Topcon NW400 robotic fundus camera. The agreement granted exclusive rights to IDx in the United States as the only autonomous AI Company permitted to sell its products with the Topcon NW400.
Nov-2017: Zebra Medical Vision signed partnership agreement with Mach7 Technologies. The partnership enabled Mach7 customers to make the leap into imaging A.I. with an affordable option that is seamlessly integrated with Mach7’s imaging platform. Together, their solution aimed to transform radiologist workflow and transform patient care by enabling A.I. where and when it is needed.
Product Launches and Product Expansions:
Jul-2020: AliveCor introduced KardiaCare, a digital health subscription service. The service provides members the control and convenience of managing heart health at home. This new service delivers exclusive digital tools to make it easier for users to interpret their heart data, monitor risk factors, identify symptom triggers, and measure the impact of positive lifestyle changes as part of a long-term heart care program.
Nov-2018: GE Healthcare unveiled the Edison healthcare artificial intelligence platform. The platform was developed for connecting data on millions of medical imaging devices. The clinical partners have been using Edison to develop algorithms and technology partners have been bringing data processing advancements to Edison applications and smart devices.
Feb-2018: Aidoc launched a comprehensive, full-body solution utilizing artificial intelligence to help analyze CT scans for radiologists. The workflow-integrated solution provides support for radiologists covering areas such as the head, c-spine, chest, and abdomen.
Mar-2017: AliveCor announced the U.S. release of Kardia Pro, an industry-first artificial intelligence-enabled platform. The platform enabled doctors to monitor patients for the early detection of atrial fibrillation.
Approvals:
Jul-2020: Zebra Medical Vision got FDA Approval for HealthMammo, an artificial intelligence tool. The tool aimed to help radiologists identify suspicious mammograms. The AI tool works by automatically sending mammograms to the analytic platform to be searched for breast lesions.
Jun-2020: VUNO got Class IIa CE markings for five of its AI solutions. These solutions are VUNO Med –BoneAge, which assists in assessing bone age based on a child’s left-hand X-ray image, reducing diagnosis time and improving accuracy; VUNO Med -DeepBrain, which segments brain regions using brain MRI data and quantifies the volumes of each region to provide atrophy volumetrics against normative database; VUNO Med -Chest X-Ray, which greatly enhances the screening function of chest X-rays by detecting the most common thoracic findings and diseases through chest X-ray images; VUNO Med –Fundus AI, it automatically detects a variety of lesions from the fundus image and quickly classifies them for diagnosis; and VUNO Med –LungCT AI, which detects and quantifies early on pulmonary nodules that can progress to lung cancer, and automatically categorizes Lung-RADS to efficiently manage multiple pulmonary nodules.
Apr-2020: VUNO announced that its first CT based pulmonary nodule detecting AI solution in Korea, VUNO Med-LungCT AI, approved by the Ministry of Food and Drug Safety. The AI solution became a valuable lung cancer diagnostic tool for healthcare professionals in Korea.
Sep-2019: GE Healthcare received FDA Approval for its Critical Care Suite, an industry-first collection of artificial intelligence (AI) algorithms embedded on a mobile X-ray device. This device has been built in collaboration with UC San Francisco (UCSF), using GE Healthcare’s Edison platform, the AI algorithms help to reduce the turn-around time it can take for radiologists to review a suspected pneumothorax, a type of collapsed lung.

Scope of the Study
Market Segmentation:

By Diagnosis Type
• Radiology
• Oncology
• Neurology
• Cardiology
• Chest & Lungs
• Pathology and
• Other Diagnosis Types

By Component
• Services
• Software and
• Hardware

By Geography
• North America
o US
o Canada
o Mexico
o Rest of North America
• Europe
o Germany
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Singapore
o Malaysia
o Rest of Asia Pacific
• LAMEA
o Brazil
o Argentina
o UAE
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA

Companies Profiled
• General Electric (GE) Co. (GE Healthcare)
• Siemens AG (Siemens Healthineers)
• Aidoc Medical Ltd.
• AliveCor, Inc.
• Imagen Technologies, Inc.
• VUNO, Inc.
• IDx Technologies, Inc.
• NovaSignal Corporation
• Riverain Technologies, LLC
• Zebra Medical Vision Ltd.

Unique Offerings from KBV Research
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

【レポートの目次】

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Artificial Intelligence in Diagnostics Market, by Diagnosis Type
1.4.2 Global Artificial Intelligence in Diagnostics Market, by Component
1.4.3 Global Artificial Intelligence in Diagnostics Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis – Global
3.1 Recent Industry Wide Strategic Developments
3.1.1 Partnerships, Collaborations and Agreements
3.1.2 Product Launches and Product Expansions
3.1.3 Approvals
3.2 Top Winning Strategies
3.2.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.2.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Nov – 2020, Jun) Leading Players
Chapter 4. Global Artificial Intelligence in Diagnostics Market by Diagnosis Type
4.1 Global Radiology Market by Region
4.2 Global Oncology Market by Region
4.3 Global Neurology Market by Region
4.4 Global Cardiology Market by Region
4.5 Global Chest & Lungs Market by Region
4.6 Global Pathology Market by Region
4.7 Global Other Diagnosis Types Market by Region
Chapter 5. Global Artificial Intelligence in Diagnostics Market by Component
5.1 Global Services Market by Region
5.2 Global Software Market by Region
5.3 Global Hardware Market by Region
Chapter 6. Global Artificial Intelligence in Diagnostics Market by Region
6.1 North America Artificial Intelligence in Diagnostics Market
6.1.1 North America Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.1.1.1 North America Radiology Market by Country
6.1.1.2 North America Oncology Market by Country
6.1.1.3 North America Neurology Market by Country
6.1.1.4 North America Cardiology Market by Country
6.1.1.5 North America Chest & Lungs Market by Country
6.1.1.6 North America Pathology Market by Country
6.1.1.7 North America Other Diagnosis Types Market by Country
6.1.2 North America Artificial Intelligence in Diagnostics Market by Component
6.1.2.1 North America Services Market by Country
6.1.2.2 North America Software Market by Country
6.1.2.3 North America Hardware Market by Country
6.1.3 North America Artificial Intelligence in Diagnostics Market by Country
6.1.3.1 USA Artificial Intelligence in Diagnostics Market
6.1.3.1.1 USA Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.1.3.1.2 USA Artificial Intelligence in Diagnostics Market by Component
6.1.3.2 Canada Artificial Intelligence in Diagnostics Market
6.1.3.2.1 Canada Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.1.3.2.2 Canada Artificial Intelligence in Diagnostics Market by Component
6.1.3.3 Mexico Artificial Intelligence in Diagnostics Market
6.1.3.3.1 Mexico Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.1.3.3.2 Mexico Artificial Intelligence in Diagnostics Market by Component
6.1.3.4 Rest of North America Artificial Intelligence in Diagnostics Market
6.1.3.4.1 Rest of North America Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.1.3.4.2 Rest of North America Artificial Intelligence in Diagnostics Market by Component
6.2 Europe Artificial Intelligence in Diagnostics Market
6.2.1 Europe Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.2.1.1 Europe Radiology Market by Country
6.2.1.2 Europe Oncology Market by Country
6.2.1.3 Europe Neurology Market by Country
6.2.1.4 Europe Cardiology Market by Country
6.2.1.5 Europe Chest & Lungs Market by Country
6.2.1.6 Europe Pathology Market by Country
6.2.1.7 Europe Other Diagnosis Types Market by Country
6.2.2 Europe Artificial Intelligence in Diagnostics Market by Component
6.2.2.1 Europe Services Market by Country
6.2.2.2 Europe Software Market by Country
6.2.2.3 Europe Hardware Market by Country
6.2.3 Europe Artificial Intelligence in Diagnostics Market by Country
6.2.3.1 Germany Artificial Intelligence in Diagnostics Market
6.2.3.1.1 Germany Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.2.3.1.2 Germany Artificial Intelligence in Diagnostics Market by Component
6.2.3.2 UK Artificial Intelligence in Diagnostics Market
6.2.3.2.1 UK Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.2.3.2.2 UK Artificial Intelligence in Diagnostics Market by Component
6.2.3.3 France Artificial Intelligence in Diagnostics Market
6.2.3.3.1 France Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.2.3.3.2 France Artificial Intelligence in Diagnostics Market by Component
6.2.3.4 Russia Artificial Intelligence in Diagnostics Market
6.2.3.4.1 Russia Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.2.3.4.2 Russia Artificial Intelligence in Diagnostics Market by Component
6.2.3.5 Spain Artificial Intelligence in Diagnostics Market
6.2.3.5.1 Spain Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.2.3.5.2 Spain Artificial Intelligence in Diagnostics Market by Component
6.2.3.6 Italy Artificial Intelligence in Diagnostics Market
6.2.3.6.1 Italy Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.2.3.6.2 Italy Artificial Intelligence in Diagnostics Market by Component
6.2.3.7 Rest of Europe Artificial Intelligence in Diagnostics Market
6.2.3.7.1 Rest of Europe Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.2.3.7.2 Rest of Europe Artificial Intelligence in Diagnostics Market by Component
6.3 Asia Pacific Artificial Intelligence in Diagnostics Market
6.3.1 Asia Pacific Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.3.1.1 Asia Pacific Radiology Market by Country
6.3.1.2 Asia Pacific Oncology Market by Country
6.3.1.3 Asia Pacific Neurology Market by Country
6.3.1.4 Asia Pacific Cardiology Market by Country
6.3.1.5 Asia Pacific Chest & Lungs Market by Country
6.3.1.6 Asia Pacific Pathology Market by Country
6.3.1.7 Asia Pacific Other Diagnosis Types Market by Country
6.3.2 Asia Pacific Artificial Intelligence in Diagnostics Market by Component
6.3.2.1 Asia Pacific Services Market by Country
6.3.2.2 Asia Pacific Software Market by Country
6.3.2.3 Asia Pacific Hardware Market by Country
6.3.3 Asia Pacific Artificial Intelligence in Diagnostics Market by Country
6.3.3.1 China Artificial Intelligence in Diagnostics Market
6.3.3.1.1 China Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.3.3.1.2 China Artificial Intelligence in Diagnostics Market by Component
6.3.3.2 India Artificial Intelligence in Diagnostics Market
6.3.3.2.1 India Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.3.3.2.2 India Artificial Intelligence in Diagnostics Market by Component
6.3.3.3 Japan Artificial Intelligence in Diagnostics Market
6.3.3.3.1 Japan Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.3.3.3.2 Japan Artificial Intelligence in Diagnostics Market by Component
6.3.3.4 South Korea Artificial Intelligence in Diagnostics Market
6.3.3.4.1 South Korea Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.3.3.4.2 South Korea Artificial Intelligence in Diagnostics Market by Component
6.3.3.5 Singapore Artificial Intelligence in Diagnostics Market
6.3.3.5.1 Singapore Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.3.3.5.2 Singapore Artificial Intelligence in Diagnostics Market by Component
6.3.3.6 Malaysia Artificial Intelligence in Diagnostics Market
6.3.3.6.1 Malaysia Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.3.3.6.2 Malaysia Artificial Intelligence in Diagnostics Market by Component
6.3.3.7 Rest of Asia Pacific Artificial Intelligence in Diagnostics Market
6.3.3.7.1 Rest of Asia Pacific Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.3.3.7.2 Rest of Asia Pacific Artificial Intelligence in Diagnostics Market by Component
6.4 LAMEA Artificial Intelligence in Diagnostics Market
6.4.1 LAMEA Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.4.1.1 LAMEA Radiology Market by Country
6.4.1.2 LAMEA Oncology Market by Country
6.4.1.3 LAMEA Neurology Market by Country
6.4.1.4 LAMEA Cardiology Market by Country
6.4.1.5 LAMEA Chest & Lungs Market by Country
6.4.1.6 LAMEA Pathology Market by Country
6.4.1.7 LAMEA Other Diagnosis Types Market by Country
6.4.2 LAMEA Artificial Intelligence in Diagnostics Market by Component
6.4.2.1 LAMEA Services Market by Country
6.4.2.2 LAMEA Software Market by Country
6.4.2.3 LAMEA Hardware Market by Country
6.4.3 LAMEA Artificial Intelligence in Diagnostics Market by Country
6.4.3.1 Brazil Artificial Intelligence in Diagnostics Market
6.4.3.1.1 Brazil Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.4.3.1.2 Brazil Artificial Intelligence in Diagnostics Market by Component
6.4.3.2 Argentina Artificial Intelligence in Diagnostics Market
6.4.3.2.1 Argentina Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.4.3.2.2 Argentina Artificial Intelligence in Diagnostics Market by Component
6.4.3.3 UAE Artificial Intelligence in Diagnostics Market
6.4.3.3.1 UAE Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.4.3.3.2 UAE Artificial Intelligence in Diagnostics Market by Component
6.4.3.4 Saudi Arabia Artificial Intelligence in Diagnostics Market
6.4.3.4.1 Saudi Arabia Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.4.3.4.2 Saudi Arabia Artificial Intelligence in Diagnostics Market by Component
6.4.3.5 South Africa Artificial Intelligence in Diagnostics Market
6.4.3.5.1 South Africa Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.4.3.5.2 South Africa Artificial Intelligence in Diagnostics Market by Component
6.4.3.6 Nigeria Artificial Intelligence in Diagnostics Market
6.4.3.6.1 Nigeria Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.4.3.6.2 Nigeria Artificial Intelligence in Diagnostics Market by Component
6.4.3.7 Rest of LAMEA Artificial Intelligence in Diagnostics Market
6.4.3.7.1 Rest of LAMEA Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.4.3.7.2 Rest of LAMEA Artificial Intelligence in Diagnostics Market by Component
Chapter 7. Company Profiles
7.1 General Electric (GE) Co. (GE Healthcare)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.1.5.3 Approvals:
7.2 Siemens AG (Siemens Healthineers)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Aidoc Medical Ltd.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Product Launches and Product Expansions:
7.3.2.2 Partnerships, Collaborations, and Agreements:
7.4 AliveCor, Inc.
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Partnerships, Collaborations, and Agreements:
7.4.2.2 Product Launches and Product Expansions:
7.5 Imagen Technologies, Inc.
7.5.1 Company Overview
7.6 VUNO, Inc.
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Approvals:
7.7 IDx Technologies, Inc.
7.7.1 Company overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.8 NovaSignal Corporation
7.8.1 Company Overview
7.9 Riverain Technologies, LLC
7.9.1 Company Overview
7.1 Zebra Medical Vision Ltd.
7.10.1 Company overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
7.10.2.2 Approvals:



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[診断における人工知能の世界市場2020-2026:診断種類別(放射線、腫瘍学、神経学、心臓病学、胸部・肺、病理学、その他)、コンポーネント別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆